Steve Lutz – Chief Executive Officer

Steve has had an exceptional career in all aspects of pharma business and commercialization. A founder of Praelia Pharmaceuticals, Steve was able to direct and develop a new health care entity into both the consumer and prescription pharmaceutical arenas.   With Cornerstone Therapeutics, Mr. Lutz was Executive Vice President of Operations as well as a founding stockholder. He was President of Aristos, Cornerstone’s generics division and achieved $40m of net profit in its first two years of operations. Steve has held various executive positions in the industry including Director, Trade Sales for Verum and acted as National Account Manager for both Biovail and Shire.  Steve holds a B.A. in Political Science and Sociology from Moravian College in Bethlehem, Pennsylvania.


Chenyqua Baldwin Shepard – Chief Financial Officer

As Chief Financial Officer, Chenyqua has full responsibility for all financial controls and reporting within Vestiq and is intimately familiar with EDI and the intricacies of accounting for drug distribution through multiple channels and through separated independent entities.  She also held the same position at Praelia Pharmaceuticals.  Chenyqua was Chief Accounting Officer, Controller and VP Finance for Cornerstone Therapeutics, Inc., as well as Director of Finance for Biovail.  Chenyqua is a fully accredited CPA with a Masters of Accounting degree and a Bachelor of Science, Business Administration Degree, both from the University of North Carolina.


Wade A. Harper – Executive Vice President of Commercial Operations

Wade Harper is a co-founder of Praelia Pharmaceuticals where he also served as Executive Vice President, Sales.  Prior to his work at Praelia, Mr. Harper served as National Sales Director for both the office-based and hospital-based sales forces at Cornerstone Therapeutics, Inc. While at Cornerstone, Mr. Harper also managed Sales Operations and Sales Analytics and acted as Regional Sales Manager.  Mr. Harper held several additional roles throughout his 15 years in the pharmaceutical industry including sales, training and management positions with both Dura and Elan Pharmaceuticals.


Randall J. Acosta – Vice President of Trade and National Accounts

Randy Acosta has over 25 years experience in both the brand and generic pharmaceutical industry with particular expertise in product commercialization, sales and distribution within trade and managed market segments. He has developed, managed and worked with numerous successful national account divisions for established and emerging pharmaceutical companies including Endo, Apotex, Sandoz and Allergan. Additionally, his expertise includes Regulatory, Quality Systems, cGMP, ISO 9000, 9001 and 13485, patent litigation, product development and FDA pathways. Randy is a graduate of California State University of Fullerton and holds a B.A. in Biological Science.


John Aiken, M. Ed. – 
Vice President of Corporate Operations, Marketing and Training

With 22 years of pharmaceutical experience, John has extensive expertise in the area of Learning and Development and Corporate Operations. Additionally, at Praelia, John also oversees marketing for the all promoted brands, including developing annual forecasts, marketing plans, promotional materials, websites, market research, etc., as well as develops/delivers all associated training for each brand. He brings a real-world perspective to adult education, including extensive experience in numerous therapeutic areas as well as vast experience in field-based and institutional selling arenas. Before joining Praelia, John was the Director of Corporate Learning & Development and Chairman of the Compliance Committee at Cornerstone Therapeutics, Inc. He has also held several senior leadership positions including Vice President Corporate Operations and Project Development for Corporate Training Consultants, Inc. John is the recipient of six awards for his work in adult learning. John holds a Masters Degree in Education with a specialization in Adult Education and Distance Learning.